NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/22/2022
Back to search
Official data from USPTO
NEOCIDE-3
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/22/2022
Trademark type
Word
Nice classes
5
Filing date
03/22/2011
Registration date
11/08/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/01/2002
First use in commerce
01/01/2003
Drawing code
4
Owner type
16
Owner location
Athens, GA, US
Examiner
EISINGER, REBECCA MILES
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
M. T. (pessoa física)
Representatives
Molecular Therapeutics
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibacterial pharmaceuticals for veterinary use; Antibacterial substances for veterinary use; Dermatological pharmaceutical products for veterinary use; Pharmaceutical preparations and substances for veterinary use for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for veterinary use for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations for veterinary use for the treatment of infectious diseases; Pharmaceutical preparations for veterinary use for the treatment of skin lesions; Pharmaceutical preparations for veterinary use in dermatology; Pharmaceutical preparations for veterinary use for wounds; Pharmaceuticalsanti-infectives for veterinary use; Therapeutic pharmaceutical for veterinary use for the treatment of skin lesions
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/22/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/05/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/08/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/02/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/02/2019
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/25/2018
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
08/01/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/25/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/27/2018
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/09/2017
E815
TEAS SECTION 8 & 15 RECEIVED
06/27/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/27/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2011
PUBO
PUBLISHED FOR OPPOSITION
08/23/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/21/2011
ALIE
ASSIGNED TO LIE
07/20/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
06/23/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/23/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
06/23/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/23/2011
DOCK
ASSIGNED TO EXAMINER
06/20/2011
MPMK
NOTICE OF PSEUDO MARK MAILED
03/29/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2011
NWAP
NEW APPLICATION ENTERED
03/25/2011
Continuous trademark protection
Get notified about every new filing that threatens NEOCIDE-3 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.